Clinical Challenges: How Early Can We Spot Alzheimer's?
Subtle preclinical changes may help target treatable disease stages
Stay updated with breaking news from Ron Petersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Subtle preclinical changes may help target treatable disease stages
Steve Wagner is a former sales coach who talked for a living – until he couldn’t.
March 13, 2021 Elizabeth Anne Brown THE WASHINGTON POST – Forget the soul – it turns out the eyes may be the best window to the brain. Changes to the retina may foreshadow Alzheimer’s and Parkinson’s diseases, and researchers said a picture of your eye could assess your future risk of neurodegenerative disease. Pinched off from the brain during embryonic development, the retina contains layers of neurons that seem to experience neurodegenerative disease along with their cousins inside the skull. The key difference is that these retinal neurons, right against the jellylike vitreous of ...
This $285 eye scan may someday detect Alzheimer's risk. (It also requires plenty of curry flavoring.) ⋮ Researchers have long sought ways to predict whether a patient will develop Alzheimer's or Parkinson's disease, but their current options are costly and impractical. Now, they're exploring whether an inexpensive picture of a patient's eye could accurately assess risk, the Washington Post's Elizabeth Brown reports. A need for early detection Experts and providers say that early detection of a patient's risk for neurodegenerative diseases could support advance planning—and potential...
Changes in retinas seem to mirror what’s going on in the brain. Researchers say eye tests may eventually lead to early treatments for some neurodegenerative ailments.